Clinical Trial Update: Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial combining dovitinib lactate, gemcitabine hydrochloride, and paclitaxel albumin-stabilized nanoparticle formulation for advanced solid tumors or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Dovitinib lactate (dovitinib)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation (paclitaxel)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer | Phase 1 | Status: WITHDRAWN